Tryptophan degradation during and after gestation

Advances in Experimental Medicine and Biology

Volumn 527, Issue , 2003, Pages 77-83

  Schröcksnadel, Katharina ^a   Widner, Bernhard ^a   Bergant, Anton ^b   Neurauter, Gabriele ^a,c   Schröcksnadel, Hans ^b   Fuchs, Dietmar ^a,c  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^c LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CYTOKINE; INDOLEAMINE 2,3 DIOXYGENASE; KYNURENINE; LIVER ENZYME; NEOPTERIN; TRYPTOPHAN; TRYPTOPHAN 2,3 DIOXYGENASE; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; DEGRADATION; ENZYME ACTIVITY; FEMALE; FETUS; HUMAN; IMMUNOREACTIVITY; MATHEMATICAL COMPUTING; NORMAL HUMAN; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; TURNOVER TIME;

POLYOMMATINAE;

EID: 1042279510     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0135-0_8     Document Type: Conference Paper

References (19)

1. Y. Ozaki, M.P. Edelstein, D.S. Duch, Induction of indoleamine 2,3-dioxygenase: a mechanism of the antitumor activity of interferon gamma, Proc. Natl. Acad. Sci. USA 85, 1242-1246 (1988).
2. A. Freese, K.J. Swartz, M.J. During, J.B. Martin, Kynurenine metabolites of tryptophan: Implications for neurologic diseases, Neurology 40, 691-695 (1990).
3. D. Fuchs, A.A. Möller, E. Stöckle, G. Reibnegger, E.R. Wemer, H. Wachter, Decreased serum tryptophan in patients with HlV-1 infection correlates with increased serum neopterin and neurologic/ psychiatric symptoms, J. Acquir Immune Defic. Syndr. 3, 873-876 (1990).
4. B. Widner, E.R. Werner, H. Schennach, H. Wachter, D. Fuchs, Simultaneous measurement of serum tryptophan and kynurenine by HPLC, Clin. Chem. 43, 2424-2426 (1997).
5. E.R. Pfefferkom, Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan, Proc. Natl. Acad. Sci. U.S.A. 81, 908-912 (1984).
6. L.M. de la Maza, E.M. Peterson, Dependence of the in vitro antiproliferative activity of recombinant human gamma-interferon on the concentration of tryptophan in culture media, Cancer Res 48, 346-350 (1988).
7. D.H. Munn, E. Shafizadeh, J.T. Attwood, I. Bondarev, A. Pashine, A.L. Mellor, Inhibition of T-cell proliferation by macrophage tryptophan catabolism, J. Exp. Med. 189, 1663-1672 (1999).
8. A.L. Mellor, D.H. Munn, Tryptophan catabolism and T-cell tolerance: Immunosuppression by starvation?, Immunol. Today 20, 469-473 (1999).
9. D.H. Munn, E. Shafidazeh, J.T. Attwood, I. Bondarev, A. Pashine, A.L. Mellor, Prevention of allogeneic fetal rejection by tryptophan catabolism, Science 81, 1191-3 (1998).
10. H. Schroecksnadel, G. Baier-Bitterlich, O. Dapunt, H. Wachter, D. Fuchs, Decreased Plasma Tryptophan in Pregnancy, Obstet. Gynecol. 88, 47-50 (1996).
11. S.L. Handley, T.L. Dunn, G. Waldron, J.M. Baker, Tryptophan, cortisol and puerperal mood, Br. J. Psychiatry 136, 498-508 (1980)
12. M. Maes, W. Ombelet, R. Verkerk, E. Bosmans, S. Scharpe, Effects of pregnancy and delivery on the availability of plasma tryptophan to the brain: relationships to delivery- induced immune activation and early post-partum anxiety and depression, Psychol. Med. 31, 847-858 (2001).
13. M. Maes, R. Verkerk, S. Bonaccorso, W. Ombelet, Depressive and anxiety symptoms in early puerperium are related to increased degradation of tryptophan into kynurenine, a phenomenon which is related to immune activation, Life Sci. in press
14. P.R. Gard, S.L. Handley, A.D. Parsons, G. Waldron, A multivariate investigation of postpartum mood disturbance, Br. J. Psychiatry 148, 567-575 (1986).
15. M.T. Abou-Saleh, R. Ghubash, L. Karim, M. Krymski, D.N. Anderson, The role of pterins and related factors in the biology of early postpartum depression, Eur. Neuropsychopharmacol. 9, 295-300 (1999).
16. K. Schröcksnadel, B. Widner, A. Bergant, G. Neurauter, H. Schennach, H. Schröcksnadel, D. Fuchs, Longitudinal study of tryptophan degradation during and after gestation, Life Sci in press.
17. K.J. Arntzen, N.B. Liabakk, G. Jacobsen, T. Espevik, R. Austgulen, Soluble tumor necrosis factor receptor in serum and urine throughout normal pregnancy and at delivery, Am. J. Reprod. Immunol. 34, 163-169 (1995)
18. Y. Kudo, C.A. Boyd, The physiology of immune evasion during pregnancy; the critical role of placental tryptophan metabolism and transport, Pflugers Arch.-Eur. J. Physiol. 442, 639-641 (2001).
19. B. Widner, M. Ledochowski, D. Fuchs, Interferon gamma-induced tryptophan degradation: neuropsychiatric and immunological consequences, Curr. Drug Metab. 1, 193-204 (2000).